BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/11/2022 8:36:00 AM | Browse: 499 | Download: 1776
 |
Received |
|
2021-05-21 09:02 |
|
Peer-Review Started |
|
2021-05-21 09:07 |
|
First Decision by Editorial Office Director |
|
2021-06-27 17:52 |
|
Return for Revision |
|
2021-06-28 04:30 |
|
Revised |
|
2021-06-28 07:18 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-06-01 02:58 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-06-03 21:27 |
|
Articles in Press |
|
2022-06-03 21:27 |
|
Edit the Manuscript by Language Editor |
|
2022-05-29 23:25 |
|
Typeset the Manuscript |
|
2022-07-02 10:51 |
|
Publish the Manuscript Online |
|
2022-07-11 08:36 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Clinical values of Barcelona Clinic Liver Cancer subgroup and up-to-7 criteria in intermediate stage hepatocellular carcinoma with transcatheter arterial chemoembolization
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shou-Wu Lee, Yen-Chun Peng, Han-Chung Lien, Chung-Wang Ko, Chun-Fang Tung and Chi-Sen Chang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shou-Wu Lee, MD, PhD, Assistant Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, No. 1650 Taiwan Boulevard, Sec. 4, Taichung 40705, Taiwan. ericest@vghtc.gov.tw |
| Key Words |
Hepatocellular carcinoma; Objective response; Overall survival; Transcatheter arterial chemoembolization; Barcelona Clinic Liver Cancer |
| Core Tip |
Transarterial chemoembolization (TACE) is the recommended treatment modality for the intermediate stage or the Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma (HCC) patients. However, due to the clinical heterogeneity in this population of patients, only some have a favorable outcome after TACE. In our study, we discovered that the intermediate stage HCC patients with smaller tumor size or within the up-to-7 criteria showed better survival outcomes for TACE. BCLC stage B subgroup is useful to predict refractoriness of HCC to TACE and to establish future therapeutic strategies. |
| Publish Date |
2022-07-11 08:36 |
| Citation |
Lee SW, Peng YC, Lien HC, Ko CW, Tung CF, Chang CS. Clinical values of Barcelona Clinic Liver Cancer subgroup and up-to-7 criteria in intermediate stage hepatocellular carcinoma with transcatheter arterial chemoembolization. World J Clin Cases 2022; 10(21): 7275-7284 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i21/7275.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i21.7275 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
